Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.

Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.

Item
http://www.wikidata.org/entity/Q34574233
Cost implications of new treatments for advanced colorectal cancer.The use of erlotinib in daily practice: a study on adherence and patients' experiences.The use of capecitabine in daily practice: a study on adherence and patients' experiencesA comparison between 5-fluorouracil/mitomycin and capecitabine/mitomycin in combination with radiation for anal cancerEconomic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancer.Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain.Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.Real-world resource use and costs of adjuvant treatment for stage III colon cancer.Cost Considerations in the Evaluation and Treatment of Colorectal Cancer.The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed.Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients.Effect of Adjuvant Chemotherapy on Elderly Colorectal Cancer Patients: Lack of Evidence.
P2860

Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.

Item
http://www.wikidata.org/entity/Q34574233
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@ast
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@en
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@nl
type
label
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@ast
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@en
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@nl
prefLabel
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@ast
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@en
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Xeloda in Adjuvant Colon Cance ...... afety, and cost-effectiveness.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698